Introduction {#Sec1}
============

Epilepsy is a chronic brain disorder characterized by recurrent seizures \[[@CR1]\]. It affects about 50 million people worldwide, and 85% of them live in developing countries. Its annual incidence is about 50 cases per 100,000 persons in developed countries and 100--190 cases per 100,000 persons in developing countries \[[@CR2]\]. The psychosocial effects of epilepsy have led to the need to quantify quality of life in epileptic patients \[[@CR3]\]. Quality of life is defined as an individual's perception of their position in life in the context of the culture and value systems in which they live \[[@CR4]\]. Quality of life is worse in epileptic patients than in the general population \[[@CR5]\]. A cross-sectional comparative study done in Kenya showed the mean quality of life among people living with epilepsy (49.90%) was significantly (p \< 0.01) lower than that of the normal controls (77.60%) accompanying them and significantly impaired as compared to the hypothesized mean of 75 ± 2.5% \[[@CR6]\]. In Ethiopia, 45.8% of epileptic patients have a poor quality of life \[[@CR7]\].

Unpredictable progression of the disease, stigma, poor self-esteem, anxiety and depression, unemployment, social isolation, and cognitive problems has been reported to impair quality of life in epileptic patients \[[@CR8]\]. Physical injuries such as burns, drowning, falls, and car accidents can endanger the lives of epileptic patients \[[@CR9]\]. The patients may isolate themselves from society because people most often stigmatize them. As a result, they can suffer from depression which may further decrease their quality of life \[[@CR10], [@CR11]\].

Apart from the disease, the antiepileptic medications can be a burden on the patients. Their side effects such as fatigue, memory problem, difficulty concentrating, and drowsiness, difficulty in thinking clearly, and nervousness or agitation affects their quality of life \[[@CR12]\]. Their side effects, especially for poly-therapies, have negatively associated with health-related quality of life, independent of seizure frequency \[[@CR13]--[@CR16]\].

However; in Africa and particularly in Ethiopia, few studies have been conducted on the health-related quality of life of epileptic patients \[[@CR17]\]. Therefore; this study was aimed to identify factors influencing health-related quality of life of patients with epilepsy in public hospitals of Wollega zones.

Main text {#Sec2}
=========

Methods {#Sec3}
-------

### Study setting and population {#Sec4}

This study was conducted in six randomly selected hospitals of Wollega zones from March 01 to March 30, 2018. The institutional based cross-sectional study design was employed. All epileptic patients on treatment follow up at selected public hospitals of Wollega zones was the source population and the sampled epileptic patients was the study population. All patients whose ages were 18 years and above were included in the study and persons who are eligible but not willing to take part in the study were excluded from the study.

### Sample size determination and sampling techniques {#Sec5}

The sample size of the study was determined using the formula for estimation of a single population proportion. 45.8% (0.458) proportion of population living with epilepsy who had poor QOL was taken from similar a study done in Addis Ababa \[[@CR7]\], and by adding a non-response rate of 5%, a total of 402 epileptic patients were involved in the study. Simple random sampling method was used to select the study participants.

### Data collection tool and procedures {#Sec6}

Data was collected using a structured questionnaire. Quality of Life questionnaire (WHOQOL BREF) scale, Hospital Anxiety and Depression scale (HADS) and stigma scale were used, and face to face interview was employed. WHOQOL-BREF contains 26 items consisting four domains were used: physical health, psychological health, social relationships, and environmental health. Each item of the WHOQOL-BREF was scored from 1 (very dissatisfied/very poor) to 5 (very satisfied/very good). Each questionnaire is scored on a scale of 24 to 120, with a higher WHOQOL score indicating better quality of life.

### Data processing and analysis {#Sec7}

The data were coded, cleaned and entered into Epi data version 3.1 and exported into SPSS window version 20.0 for analysis. Descriptive statistics were expressed in frequency, percentage, mean and standard deviation. Simple linear regression was used to find an association between dependent variable and each independent variable. Multiple linear regression with backward elimination was used to identify independent factors which best predict quality of life. All analyses were conducted at the 0.05 significance level.

### Data quality control {#Sec8}

The questionnaire was translated to the local language and then translated back to English by expertise to check for consistency. Five percent of the questionnaire was pre-tested on epileptic patients at the same study area 5 days before data collection, and some modification of the questionnaire were made. One-day training was given for data collectors and supervisors on how to collect and handle the data.

Results {#Sec9}
=======

Socio-demographic characteristics of the respondents {#Sec10}
----------------------------------------------------

Of the total of 402 study participants sampled, 392 were participated; with a response rate of 97.5%. From the total of 392 participants, 203 (51.8%) were male, and 189 (48.2%) were females. The mean age of the study participant was 30.7 years with ± 10.04 standard deviation. Majority of the study participant was unmarried, 226 (57.7%) followed by married, which accounts 145 (37.0%). Concerning educational status, 108 (27.6%) were completed grade 9--10, 105 (26.8%) were completed grade 1--8 and 71 (18.1%) have degree and above. Regarding monthly income, 124 (31.6%) gets monthly income 501--1000 EB followed by monthly income greater than 2000 EB which accounts 99 (25.3%); whereas the mean monthly income was 1490.72 ± 1183.5 SD. Concerning living condition, 333 (84.9%) live with parents (Table [1](#Tab1){ref-type="table"}).Table 1Distribution of participants by socio-demographic and clinical characteristics at public hospitals of Wollega zone, 2018 (n = 392)VariablesFrequencyPercentageGender Female18948.2 Male20351.8Ethnicity Oromo32081.6 Amhara5413.8 Gurage51.3 Tigre41.0 Others92.3 Total392100Age 18--2412531.9 25--3414737.5 35--446817.3 ≥ 455213.3 Total392100Religion Muslim4210.7 Orthodox8922.7 Protestant22657.7 Catholic276.9 Others82.0 Total392100Marital status Married14537.0 Unmarried22657.7 Widowed112.0 Divorced102.6 Total392100Educational status No formal education4411.2 Grade 1--810526.8 Grade 9--1010827.6 Diploma6416.3 Degree and above7118.1 Total392100Occupational status Gov't employee6817.3 Student6115.6 Farmer14737.5 Merchant6917.6 Daily laborers369.2 Others112.8 Total392100Residence Urban6616.8 Rural32683. 2 Total392100Monthly income ≤ 5006717.1 501--100012431.6 1001--15006817.3 1501--2000348.7 ≥ 20019925.3 Total392100Duration of disease (years) \< 2256.4 2--510627.0 6--1011328.8 \> 1014837.8 Total392100Type of epilepsy Generalized19349.2 Focal19950.8 Total392100Type of therapy Monotherapy26066.3 Polytherapy13233.7 Total392100Adverse drug reaction Yes18246.4 No21053.6 Total392100Co-morbidity of anxiety Yes11629.6 No27670.4 Total392100Co-morbidity of depression Yes4611.7 No34688.3 Total392100Perceived social stigma Yes13233.7 No26066.3 Total392100Frequency of seizure One per week16341.6 One per month13333.9 One per year6015.3 None in past year369.2 Total392100

Clinical characteristics of the respondents {#Sec11}
-------------------------------------------

Concerning the disease duration, 148 (37.8%) had duration of \> 10 years, followed by 6--10 years (28.8%). Regarding the type of epilepsy, almost half of the study participants had a focal type which is 199 (50.8%). Majority of the study participants, 210 (53.6%) had no adverse drug reaction, and 182 (46.4%) had experienced an adverse drug reaction. Regarding co-morbidity, 116 (29.6%) had anxiety, and 46 (11.7%) had depression. One hundred thirty-two, (33.7%) had perceived stigma, and 313 (79.8%) had a fear of having a seizure. Out of the total respondents, 163 (41.6%) had one seizure attacks per week followed by one seizure attacks per month, 133 (33.9%) (Table [1](#Tab1){ref-type="table"}).

Whoqol-bref (0--100) characteristics of respondents {#Sec12}
---------------------------------------------------

Descriptive statistics were performed to find out means and standard deviations of WHOQOL measurement scale. The WHOQOL BREF covers four different domains of quality of life, physical, psychological, social and environmental. The mean score for physical dimension is 17.89 ± 6.5 SD with a range of 8 to 32. The mean score for the Psychological dimension is 15.33 ± 6.17 SD with a range of 7 to 27. The mean score of social dimensions is 7.69 ± 3.24 SD with a range of 3 to 12. The mean score for environmental dimension is 19.56 ± 7.23 SD with a range of 9 to 34. The overall mean total score on the WHOQOL-BREF scale is 60.47 with ± 23.14 standard deviation. The minimum score of this WHOQOL BREF in this study is 27.00 and the maximum score is 105.00 with the range of score 78.00 (Additional file [1](#MOESM1){ref-type="media"}: Table S1).

Bivariable linear regression analysis {#Sec13}
-------------------------------------

Simple linear regression analysis was done to investigate how much each independent variable were associated with quality of life. In simple linear regression analysis, socio-demographic variables such as marital status, educational status, occupation, residence, living condition and monthly income showed significant association with quality of life. Clinical variables such as duration of disease, adverse drug reaction, co-morbidity of anxiety, comorbidity of depression, perceived social stigma and frequency of seizure were also showed significant association with health-related quality of life (Table [2](#Tab2){ref-type="table"}).Table 2Simple linear regression analysis of factors associated with Quality of life among epileptic patients attending public hospitals of Wollega zones, West Ethiopia, 2018VariablesUnstandardized coefficientStandardized coefficientt valueP-valueBetaStandard errorBetaGender Female vs male− 2.492.33− 0.05− 1.070.28Ethnicity Amhara vs Oromo2.4010.420.010.230.81 Gurage vs Oromo− 6.811.63− 0.03− 0.580.55 Tigre vs Oromo− 3.597.80− 0.02− 0.460.64Religion Muslim vs protestant− 0.273.71− 0.005− 0.070.94 Orthodox vs protestant1.243.180.020.390.69 Catholic vs protestant4.408.640.020.500.61Educational status No formal education vs ≥ degree− 8.663.07− 0.16− 2.810.005 Grade 1--8 vs ≥ degree− 10.393.05− 0.20− 3.400.001 Grade 9--10 vs ≥ degree− 7.873.55− 0.12− 2.210.027Occupation Student vs Gov't employee− 10.122.72− 0.21− 3.71\< 0.001 Farmer vs Gov't employee− 3.913.37− 0.06− 1.150.24 Merchant vs Gov't employee− 14.304.26− 0.17− 3.350.001 Daily laborers vs Gov't employee− 1.217.10− 0.009− 0.170.86Marital status Unmarried vs married− 11.597.00− 0.08− 1.700.08 Widowed vs married− 16.737.34− 0.11− 2.270.02Residence Urban vs rural8.703.080.142.820.005Monthly income ≤ 500 vs \> 2000 EB− 16.812.60− 0.33− 6.44\< 0.001 501--1000 vs \> 2000 EB− 10.123.16− 0.16− 3.200.001 1001--1500 vs \> 2000 EB− 10.584.13− 0.12− 2.550.011Living condition Alone vs with parents− 15.653.16− 0.24− 4.94\< 0.001Type of epilepsy Generalized vs focal0.652.330.010.280.77Adverse drug reaction Yes vs no− 18.492.14− 0.40− 8.62\< 0.001Co-morbidity of anxiety Yes vs no− 21.022.32− 0.41− 9.04\< 0.001Co-morbidity of depression Yes vs no− 22.353.44− 0.31− 6.48\< 0.001Fear of having seizure Yes vs no− 4.782.89− 0.08− 1.650.100Perceived social stigma Yes vs no− 13.042.38− 0.26− 5.48\< 0.001Age at onset of disease 10--19 years vs \< 10 years0.132.870.0020.040.96 20--29 years vs \< 10 years7.403.950.091.870.06 ≥ 40 years vs \< 10 years2.339.520.010.240.80Frequency of seizure One per year vs none in past year− 8.342.53− 0.17− 3.290.001 One per month vs none in past year− 19.203.27− 0.30− 5.82\< 0.001 One per week vs none in past year− 23.113.98− 0.29− 5.79\< 0.001Predictor variables: Sociodemographic and clinical variables. Dependent variables: health related quality of life

Multivariable linear regression analysis {#Sec14}
----------------------------------------

Multivariable linear regression was conducted to examine the best combination of factors for predicting quality of life. So, multivariable linear regressions model with backward elimination was used to extract factors that best predict quality of life. In the final model of multivariable linear regression, monthly income, living condition, adverse drug reaction, co-morbidity of anxiety, perceived social stigma and frequency of seizures were significantly associated with health-related quality of life. Multivariable linear regression analyses showed that monthly income ≤ 500 EB, 501--1000 EB and 1001--1500 EB were negatively associated with health-related quality of life (β = − 12.49, P \< 0.001, β = − 10.10, P \< 0.001 and β = − 8.41, P = 0.012 respectively) when compared with monthly income \> 2000 EB. The finding also showed that living alone were negatively associated with health-related quality of life (β = − 7.11, P = 0.007) when compared with those who live with their parents.

Presence of adverse drug reaction was negatively associated with health-related quality of life (β = − 10.86, P \< 0.001). The result also showed that comorbidity of anxiety was negatively influenced health related quality of life (β = − 12.99, P \< 0.001). Presence of social stigma was negatively associated with health-related quality of life (β = − 9.73, P \< 0.001), and the frequency of seizure once per week showed negative association with health-related quality of life of epileptic patients (β = − 8.4, P = 0.001). In the multivariable regression, the model is significant (F = 20.42, *P* value \< 0.001) and has an adjusted R^2^ = 0.458. The adjusted R^2^ of 0.458 (45.8%) of this model indicates that the variables included in the model explain about 45.8% of the variance or change in quality of life (Table [3](#Tab3){ref-type="table"}).Table 3Ordinary least square regression analysis of factors associated with quality of life among epileptic patients attending public hospitals of Wollega zones, West Ethiopia, 2018VariablesUnstandardized coefficientStandardized coefficientt valueP-valueMulticollinearity statisticsBetaStandard errorBetaToleranceVIFMonthly income ≤ 500 vs \> 2000 EB− 12.492.19− 0.25− 5.70\< 0.0010.711.40 501--1000 vs \> 2000 EB− 10.102.63− 0.16− 3.83\< 0.0010.741.34 1001--1500 vs \> 2000 EB− 8.413.33− 0.10− 2.520.0120.831.19Living condition Alone vs with parents− 7.112.63− 0.11− 2.700.0070.831.20Adverse drug reaction Yes vs no− 10.861.83− 0.23− 5.92\< 0.0010.881.13Co-morbidity of anxiety Yes vs no− 12.992.03− 0.25− 6.39\< 0.0010.851.16Perceived social stigma Yes vs no− 9.731.94− 0.20− 5.00\< 0.0010.871.14Frequency of seizureOne per week vs none in past year− 8.412.52− 0.13− 3.330.0010.891.12Intercept (constant) = 42.15; standard error = 3.62; t-value = 11.63; sig. \< 0.001; adjusted R square = 0.458 (45.8%), F = 20.42, P \< 0.001. Dependent variables: health related quality of life

Discussion {#Sec15}
==========

In this study, we estimated the quality of life of peoples living with epilepsy. The result showed that the mean quality of life is 60.47 ± 23.07 SD. The mean quality of life of in this study is similar with a study done in Uganda \[[@CR18]\] and Addis Ababa \[[@CR7]\]. However; the mean quality of life in the present study is lower than a study done in India \[[@CR19]\] and Malaysia \[[@CR24]\]. On the other hand, the mean quality of life of this study is higher than the study done in Russia \[[@CR20]\] and Australia \[[@CR25]\]. The possible reason for the discrepancy might be due to inadequate sample size and non-random sampling techniques in Russian study. The other possible reason could be this cross-sectional study was conducted using WHOQOL-BREF, but others were conducted using the Quality of Life Inventory for Epilepsy (QOLIE-31).

In this study, respondent's monthly income was significantly associated with health-related quality of life, which is in line with a study done in Kenya \[[@CR6]\] and in Addis Ababa at Amanuel Mental Specialized Hospital \[[@CR7]\]. The finding of this study showed that adverse drug reaction was associated with quality of life of epileptic patients. This finding is consistent with a study done in Uganda \[[@CR18]\], India \[[@CR19]\] and Russia \[[@CR20]\]. The finding of this study also showed that co-morbidity of anxiety was associated with quality of life of epileptic patients which is supported by a study done in Addis Ababa \[[@CR7]\].

Moreover, in this study, most of the respondents who had frequent seizures reported the poor quality of life. This finding is consistent with many previous studies conducted in different parts of the world \[[@CR7], [@CR18]--[@CR23]\]. This finding is also consistent with a study done in Kenya \[[@CR6]\] and Malaysia \[[@CR24]\] and Australia \[[@CR25]\]. The results of the present study also revealed that the HRQOL is significantly influenced by stigmatization about their disease, which is similar with a study done in Addis Ababa \[[@CR7]\] and Australia \[[@CR25]\]. Unlike to other studies, age, marital status, educational level and gender were not significantly associated with health-related quality of life.

Conclusion {#Sec16}
==========

The mean health-related quality of life of people living with epilepsy in this study was low. Respondent's monthly income, living condition, adverse effects of antiepileptic medications, co-morbidity of anxiety, perceived stigma, and frequency of seizure have significantly affected the quality of life of epileptic patients. The clinician should early recognize and treat drug side effects, early detect and manage comorbidity, and control seizure in order to increase quality of life of epileptic patients.

Limitation of the study {#Sec17}
=======================

The research design is cross-sectional in nature and cannot confirm causality.

Supplementary information
=========================

 {#Sec18}

**Additional file 1: Table S1.** Means and standard deviation of overall HRQOL and its subscale/dimension scores among epileptic patients attending public hospitals of Wollega Zones, West Ethiopia, 2018.

ADRs

:   adverse drug reactions

AEDs

:   anti-epileptic drugs

HADS

:   Hospital Anxiety and Depression Scales

HRQOL

:   health related quality of life

QOL

:   quality of life

QOLIE

:   quality of life in epilepsy inventory

SPSS

:   Statistical Package for Social Science

PWE

:   people with epilepsy

WHO

:   World Health Organization

WHOQOL

:   World Health Organization Quality Of Life

**Publisher\'s Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information
=========================

**Supplementary information** accompanies this paper at 10.1186/s13104-019-4720-3.

We would like to acknowledge Wollega University for financial support. We are also grateful to the study participants who voluntarily agreed to be interviewed and participated in the study.

MA involved in conceptualization of the study, designing, result writing and analyzing the finding. GM involved in designing of the study and revising a manuscript. TA participated in result writing and analyzing the finding. AO involved in writing and revising the manuscript. All authors read and approved the final manuscript.

The research was funded by Wollega University. The funding organization has no role in the design of the study, data collection, analysis, and interpretation of the data and writing the manuscript.

The data used during the current study are available from the corresponding author on request.

The study was reviewed and approved by the Institutional Review Boards of Wollega University Ethical review board. Written informed consent was obtained from the study participants before data collection.

Not applicable.

The authors declare that they have no competing interests.
